Leslie A. Andritsos, Neil Dunavin, Gerard Lozanski, Jeffrey A. Jones, James S. Blachly, David M. Lucas, John C. Byrd, Eric Kraut, Michael R. Grever. Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective. haematol [Internet]. 2014Dec.31 [cited 2024Apr.27];100(1):e18-e20. Available from: https://haematologica.org/article/view/7259